Ally Financial Inc vs Sanofi SA — how do they compare? Ally Financial Inc trades at $44.15 (market cap $13.37B), while Sanofi SA trades at $43.56 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 7.8× Ally Financial Inc's market cap, and Sanofi SA pays the higher dividend (5.55%). Which is the better fit depends on your goals.
| ALLY | SNY | |
|---|---|---|
Market Cap | $13.37B | $104.30B |
Sector | Financials | Health |
52-Week High | $47.25 | $52.34 |
52-Week Low | $35.96 | $41.33 |
Dividend Yield | 2.73% | 5.55% |
Enterprise Value | — | $124.19B |
Trailing returns across standard periods
Latest headlines on both assets
Ally Financial Inc is a diversified financial services firm that services automotive dealers and their retail customers. The company operates as a financial holding company and a bank holding company. Its banking subsidiary, Ally Bank, caters to the direct banking market through Internet, mobile, and mail. The company reports four business segments including Automotive Finance operations, Insurance operations, Mortgage Finance operations and Corporate Finance operations.
Read more on ALLY →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →